Reference
Kawamoto T, et al. Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study. Breast Cancer 30 : 282-292, No. 2, Mar 2023. Available from: URL: https://www.springer.com/journal/12282
Rights and permissions
About this article
Cite this article
Abemaciclib/palbociclib. Reactions Weekly 1965, 15 (2023). https://doi.org/10.1007/s40278-023-42983-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-42983-3